Enovis (ENOV) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2026)
Enovis (ENOV) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -6.66% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 7.81% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 10.44% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 27.51% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 61.98% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 6.01% |
| 10 | Enovis | 1.24 Bn | 1.21 Bn | 365.49 Mn | 29.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 29.05% |
| Dec 31, 2025 | -133.85% |
| Oct 3, 2025 | -101.56% |
| Jul 4, 2025 | -34.88% |
| Apr 4, 2025 | -76.52% |
| Dec 31, 2024 | -582.56% |
| Sep 27, 2024 | -30.66% |
| Jun 28, 2024 | 25.73% |
| Mar 29, 2024 | -24.14% |
| Dec 31, 2023 | -40.72% |
| Sep 29, 2023 | -71.00% |
| Jun 30, 2023 | -44.22% |
| Mar 31, 2023 | -151.98% |
| Dec 31, 2022 | -80.87% |
| Sep 30, 2022 | -297.91% |
| Jul 1, 2022 | 420.48% |
| Apr 1, 2022 | 39.56% |
| Dec 31, 2021 | -28.11% |
| Oct 1, 2021 | -56.83% |
| Jul 2, 2021 | -61.14% |